How Does ATTRv V30M Amyloidosis Affect Eye Health?

It is common to wonder why your medical team recommends regular eye exams when ATTRv V30M amyloidosis primarily affects your nerves and heart. The short answer is that the mutant transthyretin (TTR) protein that causes your condition is not only made by your liver—it is also produced directly inside your eyes. Because the eyes have a protective barrier that blocks many systemic treatments (like IV or subcutaneous silencers) from getting in, the disease can quietly progress in your eyes even if your nerve and heart symptoms are well-controlled.

The Blood-Ocular Barrier and Local TTR Production

To understand why the eyes are affected separately from the rest of the body, it helps to know how TTR is produced. The vast majority of the TTR in your bloodstream is made by your liver. However, a specialized layer of cells inside the eye, called the retinal pigment epithelium (RPE), also produces TTR locally ^[1][2][3].

Your eyes are protected by the blood-ocular barrier, a defense system of tightly joined cells that prevents harmful substances in the blood from entering the delicate tissues of the eye. While this barrier is great for keeping out toxins and infections, it also prevents systemic treatments for amyloidosis—such as gene silencers like patisiran, vutrisiran, or eplontersen—from effectively reaching the inside of the eye ^[2][4].

Some oral stabilizer medications (like tafamidis) can cross this barrier. However, stabilizers do not stop the local production of mutant TTR; instead, they work by preventing the existing protein from misfolding. Unfortunately, they may not reach high enough concentrations in the eye to fully protect against the ongoing local accumulation of amyloid ^[5][2]. Because the RPE cells continue to make the mutant TTR protein, it can still fold incorrectly and form amyloid deposits inside the eye, independently of what is happening in the rest of your body ^[3][6].

Common Eye Complications in ATTRv Amyloidosis

Because of this ongoing local production, ocular (eye) complications are very common in patients with ATTRv amyloidosis, and the risk increases the longer you have the disease ^[7][8]. The most significant eye complications to watch for include:

1. Vitreous Opacities (Floaters)
The vitreous is the clear, jelly-like substance that fills the middle of your eye. Over time, amyloid deposits can build up in this fluid ^[9][10]. These deposits cast shadows on your retina, which you might notice as vitreous opacities, commonly known as “floaters” ^[11].

• What you might notice: Dark spots, cobwebs, or string-like shapes drifting across your vision. As deposits accumulate, your vision may become generally blurry or hazy.
• Why it matters: Vitreous opacities are often the very first eye-related symptom of amyloidosis ^[12].
• What can be done: If floaters become severe and significantly impair your vision, an eye surgeon can perform a specialized procedure called a vitrectomy to remove the clouded fluid and clear your vision.

2. Secondary Glaucoma
Glaucoma is a condition where pressure inside the eye becomes too high, which can damage the optic nerve and lead to permanent vision loss ^[11]. In ATTRv amyloidosis, amyloid deposits can physically block the drainage channels of the eye, causing fluid pressure to spike. This is known as secondary glaucoma ^[13].

• What you might notice: Glaucoma often has no symptoms in its early stages. If pressure gets very high, you might experience eye pain, redness, or blurry vision.
• Why it matters: Because early glaucoma is “silent,” it is crucial that an eye doctor measures your eye pressure regularly ^[10][14]. Be sure to remind your eye doctor about your ATTRv V30M diagnosis before your exam so they understand your specific risks.
• What can be done: If it develops, secondary glaucoma requires careful management, sometimes involving specialized surgeries to help the eye drain fluid safely ^[13][15]. Catching this early makes it highly manageable.

3. Dry Eye and Pupillary Changes
While less threatening to your overall vision than glaucoma, many patients also experience severe dry eyes or changes to how their pupils respond to light. Your doctor might refer to “scalloped pupils,” which means the edges of the pupil become jagged due to amyloid deposits. These signs are important clues that amyloid is affecting the front of the eye.

The Importance of Regular Eye Screenings

Even if you are taking highly effective systemic medications that are stabilizing your heart and nerves, these drugs lack specific clinical trial evidence showing they prevent amyloidosis from progressing in the eyes ^[16][17]. Researchers are actively exploring new treatments designed specifically for the eye, such as targeted injections that might stop local TTR production ^[4][18].

Until these specific eye treatments become available, routine monitoring by an ophthalmologist (a medical eye doctor)—usually once a year, or as directed by your care team—is absolutely essential ^[10][14].

An eye doctor can use specialized tools to detect early microscopic “glass-wool” deposits in the vitreous fluid, changes to the lens, or abnormal pupillary margins long before they affect your vision ^[19][20].

Advocacy Tip: Because ATTRv amyloidosis is a rare disease, your local eye doctor may not be familiar with exactly what to look for. It is often helpful to see a retina specialist or a neuro-ophthalmologist. Most importantly, ensure your eye doctor communicates directly with your primary amyloidosis specialist to keep your entire care team on the same page.